Podophyllotoxin: Distribution, sources, applications and new cytotoxic derivatives

Toxicon

Volumn 44, Issue 4, 2004, Pages 441-459

  Gordaliza, M ^a   Garcia P A ^a   Miguel Del Corral, J M ^a   Castro, M A ^a   Gomez Zurita M A ^a  

^a UNIVERSITY OF SALAMANCA   (Spain)

Author keywords

Cyclolignan; Cytotoxicity; Isoxazopodophyllic acid; Podophyllotoxin

Indexed keywords

ALDEHYDE DERIVATIVE; ANTIDOTE; COLCHICINE; ETOPOFOS; ETOPOSIDE; INTERFERON; LIGNAN DERIVATIVE; METHOTREXATE; OXYGEN; PLANT EXTRACT; PODOPHYLLIN; PODOPHYLLOTOXIN; PODOPHYLLOTOXIN DERIVATIVE; PODOPHYLLUM EMODI EXTRACT; PODOPHYLLUM EXTRACT; PODOPHYLLUM PELTATUM EXTRACT; TENIPOSIDE; UNCLASSIFIED DRUG; VINCRISTINE;

ANTINEOPLASTIC ACTIVITY; ANTIVIRAL ACTIVITY; BIOSYNTHESIS; BIOTECHNOLOGY; CANCER CELL CULTURE; CHEMICAL STRUCTURE; CHEMISTRY; CONDYLOMA ACUMINATUM; DRUG ACTIVITY; DRUG CYTOTOXICITY; DRUG EFFICACY; DRUG ISOLATION; DRUG MECHANISM; DRUG POTENCY; DRUG SYNTHESIS; HUMAN; MEDICINAL PLANT; MULTIPLE MYELOMA; NEUROBLASTOMA; NONHUMAN; PODOPHYLLUM; PRIORITY JOURNAL; PSORIASIS VULGARIS; REVIEW; RHEUMATOID ARTHRITIS; SIDE EFFECT; TRADITIONAL MEDICINE; TUMOR CELL LINE; VASCULAR PLANT; VERRUCA VULGARIS; VIRUS REPLICATION; WART VIRUS;

CYTOTOXINS; ETOPOSIDE; LIGNANS; ORGANOPHOSPHORUS COMPOUNDS; PLANTS, TOXIC; PODOPHYLLOTOXIN; TENIPOSIDE; TUMOR CELLS, CULTURED;

EID: 4043121827     PISSN: 00410101     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.toxicon.2004.05.008     Document Type: Review

References (197)

1. Anjanamurthy C., Basavaraju Y.B. Synthesis of podophyllotoxin and related analogues: part X - tetralone esters as intermediates for synthesis of analogues of β-apopicropodophyllin. Ind. J. Chem. B 38:1999;137-140
2. Arimondo P., Boukarim C., Bailly C., Dauzonne D., Monneret C. Design of two etoposide-amsacrine conjugates: topoisomerase II and tubuline polymerization inhibition and relation to cytotoxicity. Anticancer Drug Des. 15:2000;413-421
3. Ayres D.C., Loike J.D. Lignans. Chemical, Biological and Clinical Properties. 1990;Cambridge University Press, Cambridge
4. Barret J.M., Etievant C., Baudouin C., Skov K., Charveron M., Hill B.T. F 11782, a novel catalytic inhibitor of topoisomerases I and II, induces atypical, yet cytotoxic DNA double-strand breaks in CHO-K1 cells. Anticancer Res. 22:2002;187-192
5. Basavaraju Y.B., Devaraju Y. Synthesis of analogues of podophyllotoxin: tetralones as intermediates for the synthesis of analogues of apopicropodophyllin. Ind. J. Heterocyclic Chem. 11:2002;229-232
6. Bathini Y., Scholte A., Kelly S., Micetich R.G., Daneshtalab M. New podophyllotoxin derivatives as potential anticancer agents: synthesis and cytotoxicity of 4(O-propenylpodophyllotoxin ethers. Synth. Commun. 29:1999;379-385
7. Bedir E., Khan I., Moraes R.M. Bioprospecting for podophyllotoxin. Janick J., Whipkey A. Trends in New Crops and New Uses. 2002;545-549 ASHS Press, Alexandria
8. Bedows E., Hatfield G.M. An investigation of the antiviral activity of Podophyllum peltatum. J. Nat. Prod. 45:1982;725-729
9. Bergeron R.J., Cavanaugh P.F. Jr., Kline S.J., Hugues R.G., Elliot G.T., Porter C.W. Antineoplastic and antiherpetic activity of spermidine catecholamide iron chelators. Biochem. Biophys. Res. Commun. 121:1984;848-854
10. Berkowitz D.B., Hartung R.E., Choi S. Hydrolytic enzymatic transformation of advanced synthetic intermediates: on the choice of the organic cosolvent. Tetrahedron: Asymmetry. 10:1999;4513-4520
11. Berkowitz D.B., Choi S., Maeng J.H. Enzyme-assisted asymmetric total synthesis of (-)-podophyllotoxin and (-)-picropodophyllin. J. Org. Chem. 65:2000;847-860
12. Berkowitz D.B., Choi S.J., Bhuniya D., Shoemaker R.K. Novel reverse Kahne-type glycosylation: access to O-, N-, and C-linked epipodophyllotoxin conjugates. Org. Lett. 2:2000;1149-1152
13. Beutner K.R. Podophyllotoxin in the treatment of genital warts. Curr. Probl. Dermatol. 24:1996;227-232
14. Botta B., Delle Monache G., Misiti D., Vitali A., Zappia G. Aryltetralin Lignans: Chemistry, Pharmacology and Biotransformations. Curr. Med. Chem. 8:2001;1363-1381
15. Bromhead A.J., Rahman M.M., Dewick P.M., Jackson D.E., Lucas J.A. Matairesinol as precursor of Podophyllum lignans. Phytochemistry. 30:1991;1489-1492
16. Broughton H.B., Gordaliza M., Castro M.A., Miguel del Corral J.M., San Feliciano A. Modified CoMFA methods for the analysis of antineoplastic effects of lignan analogues. J. Mol. Struct. (TheoChem). 504:2000;287-294
17. Buss A.D., Waigh R.D. Wolff M.E. Natural Products as Leads for New Pharmaceuticals. 1995;Wiley, New York. chapter 24
18. Canel C., Moraes R.M., Dayan F.E., Ferreira D. Molecules of interest "podophyllotoxin'. Phytochemistry. 54:2000;115-120
19. Canel C., Dayan F.E., Ganzera M., Khan I.A., Rimando A., Burandt C.L., Moraes R.M. High yield of podophyllotoxin from leaves of Podophyllum peltatum by in situ conversion of podophyllotoxin 4-O-β-D-glucopyranoside. Planta Med. 67:2001;97-99
20. Capilla A.S., Sanchez I., Caignard D.H., Renard P., Pujol M.D. Antitumor agents: synthesis and biological evaluation of new compounds related to podophyllotoxin, containing the 2,3-dihydro-1,4-benzodioxin system. Eur. J. Med. Chem. 36:2001;389-393
21. ®) in patients with rheumatoid arthritis. Scand. J. Rheumatol. 29:2000;89-94
22. Castro M.A., Gordaliza M., Miguel del Corral J.M., San Feliciano A. Distribution of lignanoids in the order coniferae. Phytochemistry. 41:1996;995-1011
23. Castro M.A., Miguel del Corral J.M., Gordaliza M., Grande C., Gómez-Zurita M.A., García-Grávalos M.D., San Feliciano A. Síntesis and cytotoxicity of podophyllotoxin analogues modified in the A-ring. Eur. J. Med. Chem. 38:2003;65-74
24. Castro M.A., Miguel del Corral J.M., Gordaliza M., Gómez-Zurita M.A., De la Puente M.L., Betancur-Galvis L.A., Sierra J., García- Grávalos M.D., San Feliciano A. Synthesis, cytotoxicity and antiviral activity of podophyllotoxin analogues modified in the E-ring. Eur. J. Med. Chem. 38:2003;899-911
25. Charruault L., Michelet V., Genet J.P. Pd-catalyzed route to (+/-)-podophyllotoxin skeleton. Synthesis of the aryltetralin derivative. Tetrahedron Lett. 43:2002;4757-4760
26. Chattopadhyay S., Srivastava A.K., Bhojwani S.S., Bisaria V.S. Development of suspension culture of Podophyllum hexandrum for production of podophyllotoxin. Biotechnol. Lett. 23:2001;2063-2066
27. Chattopadhyay S., Srivastava A.K., Bhojwani S.S., Bisaria V.S. Production of podophyllotoxin by plant cell cultures of Podophyllum hexandrum in bioreactor. J. Biosci. Bioeng. 93:2002;215-220
28. Chattopadhyay S., Srivastava A.K., Bisaria V.S. Optimization of culture parameters for production of podophyllotoxin in suspension culture of Podophyllum hexandrum. Appl. Microbiol. Biotechnol. 102:2002;381-393
29. Chattopadhyay S., Mehra R.S., Srivastava A.K., Bhojwani S.S., Bisaria V.S. Effect of major nutrients on podophyllotoxin production in Podophyllum hexandrum suspension cultures. Appl. Microbiol. Biotechnol. 60:2003;541-546
30. Chaudhuri A.R., Seetharamalu P., Schwarz P.M., Hausheer F.H., Luduena R.F. The interaction of the B-ring of colchicine with α-tubulin: a novel footprinting approach. J. Mol. Biol. 303:2000;679-692
31. Chen S.Y., Yu Y.P., You J.Z., Chen Y.Z. Two new methods for synthesis of 4 β-amino-4-deoxypodophyllotoxin and 4 β-amino-4′-demethyl-4- deoxypodophyllotoxin. Chem. J. Chin. Univ. 21:2000;1064-1066
32. Chiung Y.M., Hayashi H., Matsumoto H., Otani T., Yoshida K., Huang M.Y., Chen R.X., Liu J.R., Nakayama M. New metabolites, tetrahydrofuran lignans, produced by Streptomyces sp. IT-44. J. Antibiot. 47:1994;487-491
33. Cho S.J., Kashiwada Y., Bastow K.F., Cheng Y.C., Lee K.H. Antitumor agents 164, podophenazine, 2″,3″-dichloropodophenazine, benzopodophenazine, and their 4 β-p-nitroaniline derivatives as novel DNA topoisomerase II inhibitors. J. Med. Chem. 39:1996;1396-1402
34. Claesson U., Lassus A., Happonen H., Hostrom L., Siboulet A. Topical treatment of venereal warts: a comparative open study of podophyllotoxin cream versus solution. Int. J. STD AIDS. 7:1996;429-434
35. Clayden J., Kenworthy M.N., Helliwell M. Dearomatizing cyclization of arylsufonylalkoxymethyl lithiums: a route to the podophyllotoxin skeleton. Org. Lett. 5:2003;831-834
36. Costa M.C.A., Takahata Y. Conformational analysis of synthetic neolignans active against leishmaniasis, using the molecular mechanics method (MM2). J. Comput. Chem. 18:1997;712-721
37. Couture S.O. First synthesis and pharmacological evaluation of benzoindolizidine and benzoquinolizidine analogues of α- and β-peltatin. Bioorg. Med. Chem. 8:2000;2113-2125
38. Cowan C.R., Cande W.Z. Meiotic telomere clustering is inhibited by colchicine but does not require cytoplasmic microtubules. J. Cell Sci. 115:2002;3747-3756
39. Cui Y.J., Tian X.A. Synthesis and anticancer activity of new derivatives of podophyllotoxin. Curr. Sci. 75:1998;1383-1386
40. Daley L., Meresse P., Bertounesque E., Monneret C. A one-pot, efficient synthesis of the potent cytotoxic podophyllotoxin derivative NPF. Tetrahedron Lett. 38:1997;2673-2676
41. Daley L., Guminski Y., Demerseman P., Kruczynski A., Etievant C., Imbert T., Hill B.T., Monneret C. Synthesis and antitumor activity of new glycosides of epipodophyllotoxin, analogues of etoposide, and NK 611. J. Med. Chem. 41:1998;4475-4485
42. Damayanthi Y., Lown J.W. Podophyllotoxins: current status and recent developments. Curr. Med. Chem. 5:1998;205-252
43. Datt M., Sharma A. Vinblastine-podophylotoxin, a good mitotic agent for preparing embryonic chromosomes. Ind. J. Anim. Sci. 70:2000;912-913
44. Davin L.B., Wang H.B., Crowell A.L., Bedgar D.L., Martin D.M., Sarkanen S., Lewis N.G. Stereoselective bimolecular phenoxy radical coupling by an auxiliary (dirigent) protein without an active center. Science. 275:1997;362-366
45. Dekebo A., Lang M., Polborn K., Dagne E., Steglich W. Four lignans from Commiphora erlangeriana. J. Nat. Prod. 65:2002;1252-1257
46. Delorme D., Ducharme Y., Brideau C., Chan C.C., Chauret N., Desmarais S., Dube D., Falgueyret J.P., Fortin R., Guay J., Hamel P., Jones T.R., Lepine C., McAuliffe M., McFarlane C.S., Nicoll-Griffith D.A., Riendeau D., Yergey J.A., Girard Y. Dioxabicyclooctanyl naphthalenenitriles as nonredox 5-lipoxygenase inhibitors: structure-activity relationship study directed toward the improvement of metabolic stability. J. Med. Chem. 39:1996;3951-3970
47. Dhar U., Manjkhola S., Joshi M., Bhatt A., Bisht A.K., Joshi M. Current status and future strategy for development of medicinal plants sector in Uttaranchal, India. Curr. Sci. 83:2002;956-964
48. Eich E., Schulz J., Kaloga M., Merz H., Schoder H.C., Muller W.E.G. Interference of epipodophyllotoxins and natural lignanolides with topoisomerase II: a proposed molecular mechanism. Planta Med. 57:(Suppl. 2):1991;A7
49. Eich E., Pertz H., Kaloga M., Schulz J., Fesen M.R., Mazumder A., Pommier Y. (-)-Arctigenin as a lead structure for inhibitors of human immunodeficiency virus type-1 integrase. J. Med. Chem. 39:1996;86-95
50. Empt U., Alfermann A.W., Pras N., Petersen M. The use of plant cell cultures for the production of podophyllotoxin and related lignans. J. Appl. Bot. 74:2000;145-150
51. Fisher R.I., Gaynor E.R., Dahlberg S., Oken M.M., Grogan T.M., Mize E.M., Glick J.M., Coltman C.A. Jr., Miller T.P. A phase III comparison of CHOP vs. m-BACOD vs. ProMACE-CytaBOM vs. MACOP-B in patients with intermediate- or high-grade non-Hodgkin's's lymphoma: results of SWOG-8516 (Intergroup 0067), the national high-priority lymphoma study. Ann. Oncol. 5:(Suppl 2):1994;91-95
52. Fleming R.A., Miller A.A., Steward C.F. Etoposide: an update. Clin. Pharm. 8:1989;274-293
53. Fransen M.C.R., Walton M.J. Biotransformations. Walton M.J., Brawn D.E. Chemicals from Plants. Perspectives on Plant Secondary Products. 1999;277-325 Imperial College Press, London
54. Galland J.C., Dias S., Savignac M., Genet J.P. Cycloisomerization of 1,6-enynes in organoaqueous medium: an efficient and eco-friendly access to furan derivatives. Synthesis of a key intermediate of podophyllotoxin. Tetrahedron. 57:2001;5137-5148
55. Gan X.H., Robin J.P., Mencia-Huerta J.M., Braquet P., Bonavida B. Inhibition of tumor necrosis factor-α (TNF-α) and interleukin-1 β (IL-1 β) secretion but not IL-6 from activated human peripheral blood monocytes by a new synthetic demethylpodophyllotoxin derivative. J. Clin. Immunol. 14:1994;280-288
56. Ganzera M., Moraes R.M., Khan I.A. Separation of Podophyllum lignans by micellar electrokinetic capillary chromatography (MECC). Chromatographia. 49:1999;552-556
57. P.A. García, 2000. Modificación molecular de ciclolignanos antineoplásicos selectivos. Doctoral Thesis, Facultad de Farmacia, Salamanca University, Spain.
58. Garcia E.S., Cabral M.M.O., Schaub G.A., Gottlieb O.R., Azambuja P. Effects of lignoids on a hematophagous bug. Rhodnius prolixus: feeding, ecdysis and diuresis. Phytochemistry. 55:2000;611-616
59. Garzino F., Meou A., Brun P. A new approach toward the synthesis of heterolignans. Tetrahedron Lett. 43:2002;5049-5051
60. Ghisalberti E.L. Cardiovascular activity of naturally occurring lignans. Phytomedicine. 4:1997;151-166
61. Giri A., Narasu M.L. Production of podophyllotoxin from Podophyllum hexandrum: a potential natural product for clinically useful anticancer drugs. Cytotechnology. 34:2000;17-26
62. Giri A., Narasu M.L. Transgenic hairy rotos: recent trends and applications. Biotechnol. Adv. 18:2000;1-22
63. M.A. Gómez-Zurita, 2003. Ciclolignanos citotóxicos derivados de podofilotoxina. Nuevos análogos nitrogenados. Doctoral Thesis, Facultad de Farmacia, Salamanca University, Spain.
64. Gordaliza M., Miguel del Corral J.M., Castro M.A., López- Vázquez M.L., San Feliciano A., García-Grávalos M.D., Carpy A. Synthesis and evaluation of pyrazolignans. A new class of cytotoxic agents. Bioorg. Med. Chem. 3:1995;1203-1210
65. Gordaliza M., Castro M.A., Miguel del Corral J.M., López- Vázquez M.L., San Feliciano A., Faircloth G.T. In vivo immunosuppressive activity of some cyclolignans. Bioorg. Med. Chem. Lett. 7:1997;2781-2786
66. Gordaliza M., Castro M.A., Miguel del Corral J.M., San Feliciano A. Antitumor properties of podophyllotoxin and related compounds. Curr. Pharm. Des. 6:2000;1811-1839
67. Gordaliza M., Castro M.A., Miguel del Corral J.M., López-Vazquez M.L., García P.A., García-Grávalos M.D., San Feliciano A. Synthesis and antineoplastic activity of cyclolignan aldehydes. Eur. J. Med. Chem. 35:2000;691-698
68. Gordaliza M., Miguel del Corral J.M., Castro M.A., García- García P.A., San Feliciano A. Cytotoxic cyclolignans related to podophyllotoxin. Il Fármaco. 56:2001;297-304
69. Greenwald R.B., Conover C.D., Pendri A., Choe Y.H., Martinez A., Wu D.C., Guan S.Y., Yao Z.L., Shum K.L. Drug delivery of anticancer agents: water soluble 4-poly (ethylene glycol) derivatives of the lignan podophyllotoxin. J. Controlled Release. 61:1999;281-294
70. Gu J.Q., Park E.J., Totura S., Riswan S., Fong H.H.S., Pezzuto J.M., Kinghorn A.D. Constituents of the twigs of Hernandia ovigera that inhibit the transformation of JB6 murine epidermal cells. J. Nat. Prod. 65:2002;1065-1068
71. Guo L.W., Gao X., Zhang D.W., Wu S.H., Wu H.M. Synthesis of [60]fullerene-podophyllotoxin derivative. Chin. J. Chem. 20:2002;1430-1433
72. Hammonds T.R., Denyer S.P., Jackson D.E., Irving W.L. Studies to show that with podophyllotoxin the early replicative stages of herpes simplex virus type 1 depend upon functional cytoplasmic microtubules. J. Med. Microb. 45:1996;167-172
73. Hara H., Fujihashi T., Sakata T., Kaji A., Kaji H. Tetrahydronaphthalene lignan compounds as potent anti-HIV type 1 agents. Aids Res. Hum. Retroviruses. 13:1997;695-705
74. Hermanns L.T., Arrese J.E., Goffin V., Pierard G.E. Podophyllotoxin- induced acantholysis and cytolysis in a skin equivalent model. Eur. J. Morphol. 36:1998;183-187
75. Hitotsuyanagi Y., Kobayashi M., Morita H., Itokawa H., Takeya K. Synthesis of (-)-4-aza-4-deoxypodophyllotoxin from (-)-podophyllotoxin. Tetrahedron Lett. 40:1999;9107-9110
76. Hitotsuyanagi Y., Fukuyo M., Tsuda K., Kobayashi M., Ozeki A., Itokawa H., Takeya K. 4-aza-2,3-dehydro-4-deoxypodophyllotoxins: simple aza-podophyllotoxin analogues possessing potent cytotoxicity. Bioorg. Med. Chem. Lett. 10:2000;315-317
77. Huang T.S., Lee C.C., Chao Y., Shu C.H., Chen L.T., Chen L.L., Chen M.H., Yuan C., Whang-Peng J. A novel podophyllotoxin-derived compound GL331 is more potent than its congener VP-16 in killing refractory cancer cells. Pharmaceut. Res. 16:1999;997-1002
78. Huang T.S., Shu C.H., Lee C.C., Chen L.T., Whang-Peng J. In vitro evaluation of GL331's cancer cell killing and apoptosis-inducing activity in combination with other chemotherapeutic agents. Apoptosis. 5:2000;79-85
79. Iida H., Lown J.W. Practical route to introduce lexitropsins possessing a natural trisulfide linker; synthesis of N-(lexitropsin-thiosulfenyl) phthalimides. Heterocyclic Commun. 4:1998;525-528
80. Iida A., Kano M., Kubota Y., Koga K., Tomioka K. Podophyllotoxin aza-analogue, a novel DNA topoisomerase II inhibitor. Chem. Pharm. Bull. 48:2000;486-489
81. Imbert T.F. Discovery of podophyllotoxins. Biochimie. 80:1998;207-222
82. Inamori Y., Kubo M., Tsujibo H., Ogawa M., Baba K., Kozawa M., Fujita E. The biological activities of podophyllotoxin compounds. Chem. Pharm. Bull. 34:1986;3928-3932
83. Iwasaki T., Kondo K., Nishitani T., Kuroda T., Hirakoso K., Ohtani A., Takashima K. Arylnaphthalene lignans as novel series of hypolipidemic agents raising high-density lipoprotein level. Chem. Pharm. Bull. 43:1995;1701-1705
84. Iwasaki T., Kondo K., Kuroda T., Moritani Y., Yamagata M., Sugiura H., Kikkawa H., Kaminuma O., Ikezawa K. Novel selective PDE IV inhibitors as antiasthmatic agents. Synthesis and biological activities of a series of 1-aryl-2,3-bis(hydroxymethyl) naphthalene lignans. J. Med. Chem. 39:1996;2696-2704
85. Jackson D.E., Dewick P.M. Aryltetralin lignans from Podophyllum hexandrum and Podophyllum peltatum. Phytochemistry. 23:1984;1147-1152
86. Jia Z.P., Wang R., Xie J.W., Xu L.T. Action of free radical in podophyllic acid piperindyl hydrazone nitroxide radical on its antitumor activity and toxicity. Acta Pharm. Sin. 20:1999;571-576
87. Jie M.S.F.L.K., Mustafa J., Pasha M.K. Synthesis and spectral characteristics of some unusual fatty esters of podophyllotoxin. Chem. Phys. Lipids. 100:1999;165-170
88. Kamal A., Laxman N., Ramesh G. Facile and efficient one-pot synthesis of 4β-arylamino-podophyllotoxins: synthesis of DNA topoisomerase II inhibitors (NPF and W-68). Bioorg. Med. Chem. Lett. 10:2000;2059-2062
89. Katritzky A.R., Cobo-Domingo J., Yang B.Z., Steel P.J. Stereospecific synthesis of oxazolo[3,4-b]tetrahydroisoquinolin-3-ones, analogs of podophyllotoxin, via benzotriazole methodology. Tetrahedron: Asymmetry. 10:1999;255-263
90. Kim Y., You Y.J., Nam N.H., Ahn B.Z. Prodrugs of 4′-demethyl-4- deoxypodophyllotoxin: synthesis and evaluation of the antitumor activity. Bioorg. Med. Chem. 2:2002;3435-3438
91. Kuroda T., Kondo K., Iwasaki T., Ohtani A., Takashima K. Synthesis and hypolipidemic activity of diesters of arylnaphthalene lignan and their heteroaromatic analogs. Chem. Pharm. Bull. 45:1997;678-684
92. Kutney J.P. Biotechnology and synthetic chemistry - routes to clinically important compounds. Pure Appl. Chem. 71:1999;1025-1032
93. Lassus A. Comparison of podophyllotoxin and podophyllin in treatment of genital warts. Lancet. 2:1987;512-513
94. K. Leander, B. Rosen, 1988. Medicinal used for podophyllotoxin. US patent, 4,788,216.
95. Lee K.H. Novel antitumor agents from higher plants. Med. Res. Rev. 19:1999;569-596
96. Lee C.C., Huang T.S. A novel topoisomerase II poison GL331 preferentially induces DNA cleavage at (C/G) T sites and can cause telomere DNA damage. Acta Pharm. Res. 18:2001;846-851
97. Lee C.T.L., Lin V.C.K., Zhang S.X., Zhu X.K., Vliet D.V., Hu H., Beers S.A., Wang Z.Q., Cosentino L.M., Morris-Natschke S.L., Lee K.H. Anti-AIDS agents. 29. Anti-HIV activity of modified podophyllotoxin derivatives. Bioorg. Med. Chem. Lett. 7:1997;2897-2902
98. Legrand A., Rigo B., Gautret P., Henichart J.P., Couturier D. Studies on pyrrolidinone. Synthesis of aza analogs of podophyllotoxin and related compounds. J. Heterocyclic Chem. 36:1999;1263-1270
99. Lerndal T., Svensson B. A clinical study of CPH 82 vs. methotrexate in early rheumatoid arthritis. Rheumatology (Oxford). 39:2000;316-320
100. Li W.G., Zhang X.Y., Wu Y.J., Tian X.A. Antioxidative activity of spin labeled derivatives of podophyllic acid hydrazide. Acta Pharm. Sin. 23:2002;727-732
101. Lim Y.H., Leem M.J., Shin D.H., Chang H.B., Hong S.W., Moon E.Y., Lee D.K., Yoon S.J., Woo W.S. Cytotoxic constituents from the roots of Anthriscus sylvestris. Arch. Pharmacol. Res. 22:1999;208-212
102. Lin S.K., Huang H.C., Chen L.L., Lee C.C., Huang T.S. GL331 induces down-regulation of cyclin D1 expression via enhanced proteolysis and repressed transcription. Mol. Pharmacol. 60:2001;768-775
103. Liu K.C.S.C., Lee S.S., Lin M.T., Chang C.W., Liu C.L., Lin J.Y., Hsu F.L., Ren S., Lien E.J. Lignans and tannins as inhibitors of viral reverse transcriptase and human DNA polymerase-α: QSAR analysis and molecular modeling. Med. Chem. Res. 7:1997;168-179
104. Liu S.H., Tian X., Chen X.G., Hu Z.D. Separation and determination of podophyllum lignans by micellar electrokinetic chromatography. J. Chromatography. 928:2001;109-115
105. Liu S.H., Tian X., Chen X.G., Hu Z.D. Micellar electrokinetic capillary chromatographic separation of diastereoisomers of podophyllum lignans at the C4 position. Chromatographia. 56:2002;687-691
106. Liu S.H., Tian X., Chen X.G., Hu Z.D. Separation of diastereoisomers of podophyllum lignans by micellar electrokinetic chromatography. J. Chromatography. 959:2002;263-268
107. Lloyd A.W. Aza-podophyllotoxin as potent cytotoxic agents. Drug Discov. Today. 5:2000;260
108. López-Pérez J.L., del Olmo E., de Pascual Teresa B., Merino M., Barajas M., San Feliciano A. A role for dipole moment in the activity of cyclolignans. J. Mol. Struct. (Theochem). 504:2000;51-57
109. Mac Donald T.L., Lehnert E.K., Loper J.T., Chow K.C., Ross W.E. Potmensil M., Kohn K.W. DNA Topoisomerase in Cancer. 1992;Oxford University Press, New York
110. MacRae W.D., Hudson J.B., Towers G.H. The antiviral action of lignans. Planta Med. 55:1989;531-535
111. Madrigal B., Puebla P., Caballero E., Pelaez R., Gravalos D.G., Medarde M. Synthesis of imidazo[4,5-d]oxazolo[3,4-a]pyridines. New heterocyclic analogues of lignans. Arch. Pharm. 334:2001;177-179
112. Madrigal B., Puebla P., Pelaez R., Caballero E., Medarde M. Naphthalene analogues of lignans. J. Org. Chem. 68:2003;854-864
113. Maqbool M., Cushman K.E., Moraes R.M. Mayapple: a review of the literature from a horticultural perspective. Annual Report of the North Mississippi Research and Extension Center. Miss. Agric. For. Expt Sta. Info. Bull. 375:2001;313-319
114. Markos A.R. The successful treatment of Molluscum contagiosum with podophyllotoxin (0.5%) self-application. Int. J. STD AIDS. 12:2001;833
115. Massanet G.M., Pando E., Rodríguez-Luis F., Zubia E. Lignans: a review. Fitoterapia. 60:1989;3-35
116. Masuda T., Oyama Y., Yonemori S., Takeda Y., Yamazaki Y., Mizuguchi S., Nakata M., Tanaka T., Chikahisa L., Inaba Y., Okada Y. Flow cytometric estimation on cytotoxic activity of leaf extracts from seashore plants in subtropical Japan: Isolation, quantification and cytotoxic action of (-)-deoxypodophyllotoxin. Phytother. Res. 16:2002;353-358
117. Masunari A., Ishida E., Trazzi G., Almeida W.P., Coelho F. An alternative route to the synthesis of lignans intermediates. Synth. Commun. 31:2001;2127-2136
118. Meresse P., Bertounesque E., Imbert T., Monneret C. Synthetic approaches to condensed aromatic analogues from etoposide, synthesis of A-ring pyridazine picroetoposide. Tetrahedron. 55:1999;12805-12818
119. Mikame K., Sakakibara N., Umezawa T., Shimada M. Lignans of Linum flavum var. compactum. J. Wood Sci. 48:2002;440-445
120. Mittal A., Pathania V., Agrawala P.K., Prasad J., Singh S., Goel H.C. Influence of Podophyllum hexandrum on endogenous antioxidant defence system in mice: possible role in radioprotection. J. Ethnopharmacol. 76:2001;253-262
121. Miyata L., Itoh K., Tachibana S. Extractives of Juniperus chinensis L. - I: isolation of podophyllotoxin and yatein from the leaves of J. chinensis. J. Wood Sci. 44:1998;397-400
122. Miyazawa M., Fukuyama M., Yoshio K., Kato T., Ishikawa Y. Biologically active components against Drosophila melanogaster from Podophyllum hexandrum. J. Agric. Food Chem. 47:1999;5108-5110
123. Molog G.A., Empt U., Kuhlmann S., van Uden W., Pras N., Alfermann A.W., Petersen M. Deoxypodophyllotoxin 6-hydroxylase, a cytochrome P450 monooxygenase from cell cultures of Linum flavum involved in the biosynthesis of cytotoxic lignans. Planta. 214:2001;288-294
124. Moraes R.M., Burandt C. Jr., Ganzera M., Li X., Khan I., Canel C. The american mayapple revisited - Podophyllum peltatum - still a potential cash crop? Econ. Bot. 54:2001;471-476
125. Moraes R.M., Bedir E., Barrett H., Burandt C., Canel C., Khan I.A. Evaluation of Podophyllum peltatum accessions for podophyllotoxin production. Planta Med. 68:2002;341-344
126. Moraes-Cedeira R.M., Burandt C.L. Jr., Bastos J.K., Nanayakkara N.P.D., McChesney J.D. In vitro propagation of P. peltatum. Planta Med. 64:1998;42-46
127. Moss G.P. Nomenclature of lignans and neolignans. Pure Appl. Chem. 72:2000;1493-1523
128. Nadeem M., Palni L.M.S., Purohit A.N., Pandey H., Nandi S.K. Propagation and conservation of Podophyllum hexandrum Royle: an important medicinal herb. Biol. Conserv. 92:2000;121-129
129. Nanjundaswamy N., Shashikanth S., Anjanamurthy C., Rai K.M.L. Tetralone esters as intermediates for the synthesis of podophyllotoxin derivatives via cyclopropanation of chalcones. Synth. Commun. 30:2000;1179-1191
130. Nanjundaswamy N., Shashikanth S., Anjanamurthy C., Rai K.M.L. Synthesis of podophyllotoxin analogues. XII. Synthesis of β-apopicropodophyllin analogues. Synth. Commun. 32:2002;1475-1482
131. Oliva A., Moraes R.M., Watson S.B., Duke S.O., Dayan F.E. Aryltetralin lignans inhibit plant growth by affecting the formation of mitotic microtubular organizing centers. Pestic. Biochem. Physiol. 72:2002;45-54
132. Oostdam A., Mol J.N.M., Vanderplas L.H.W. Establishment of hairy root cultures of Linum flavum producing the lignan 5-methoxy podophyllotoxin. Plant Cell Rep. 12:1993;474-477
133. Pal D., Mahapatra P., Manna T., Chakrabarti P., Bhattacharyya B., Banerjee A., Basu G., Roy S. Conformational properties of α-tubulin tail peptide: implications for a tail-body interaction. Biochemistry. 40:2001;15512-15519
134. Pandey H., Nandi S.K., Chandra B., Nadeem M., Palni L.M.S. GA(3) induced flowering in Podophyllum hexandrum Royle: a rare alpine medicinal herb. Acta Physiol. Plant. 23:2001;467-474
135. Petersen M., Alfermann A.W. The production of cytotoxic lignans by plant cell cultures. Appl. Microbiol. Biotechnol. 55:2001;135-142
136. Poli G., Giambastiani G. An epiisopicropodophyllin aza analogue via palladium-catalyzed pseudo-domino cyclization. J. Org. Chem. 67:2002;9456-9459
137. Pugh N.I., Khan I., Moraes R.M., Pasco D. Podophyllotoxin lignans enhance IL-1E but suppress TNF-a mRNA expression in LPS-treated monocytes. Immunopharmacol. Immunotoxicol. 23:2001;83-95
138. Puricelli L., Innocenti G., Piacente S., Caniato R., Filippini R., Capelletti E.M. Production of lignans by Haplophyllum patavinum in vivo and in vitro. Heterocycles. 56:2002;607-612
139. Purohit M.C., Bahuguna R., Maithani U.C., Purohit A.N., Rawat M.S.M. Variation in podophylloresin and podophyllotoxin contents in different populations of Podophyllum hexandrum. Curr. Sci. 77:1999;1078-1080
140. Ramos A.C., de Clairac R.P.L., Medarde M. Heterolignans. Heterocycles. 51:1999;1443-1470
141. Ramos A.C., Pelaez R., Lopez J.L., Caballero E., Medarde M., San Feliciano A. Heterolignanolides, Furo- and thieno-analogues of podophyllotoxin and thuriferic acid. Tetrahedron. 57:2001;3963-3977
142. Rantapaa-Dahlqvist S., Landberg G., Roos G., Norberg B. Cell cycle effects of the anti-rheumatic agent CPH82. Br. J. Rheumatol. 33:1994;327-331
143. Rassmann I., Thodtmann R., Mross M., Huttmann A., Berdel W.E., Manegold C., Fiebig H.H., Kaeser-Frohlich A., Burk K., Hanauske A.R. Phase I clinical and pharmacokinetic trial of the podophyllotoxin derivative NK611 administered as intravenous short infusion. Invest. New Drugs. 16:1998;319-324
144. Roulland E., Bertounesque E., Huel C., Monneret C. Synthesis of picropodophyllin homolactone. Tetrahedron Lett. 41:2000;6769-6773
145. Roulland E., Magiatis P., Arimondo P., Bertounesque E., Monneret C. Hemi-synthesis and biological activity of new analogues of podophyllotoxin. Bioorg. Med. Chem. 10:2002;3463-3471
146. Row R. Chemistry of Lignans. Andhra University Press. 1978
147. Samanta N., Goel H.C. Protection against radiation induced damage to spermatogenesis by Podophyllum hexandrum. J. Ethnopharmacol. 81:2002;217-224
148. Schacter L. Etoposide phosphate: what, why, where, and how? Semin. Oncol. 6:(Suppl 13):1996;1-7
149. Schonbrunn E., Phlippen W., Trinczek B., Sack S., Eschenburg S., Mandelkow E.M., Mandelkow E. Crystallization of a macromolecular ring assembly of tubulin liganded with the anti-mitotic drug podophyllotoxin. J. Struct. Biol. 128:1999;211-215
150. Schwartz J., Norton S.A. Useful plants of dermatology. VI. The mayapple (Podophyllum). J. Am. Acad. Dermatol. 47:2002;774-775
151. Seidel V., Windhovel J., Eaton G., Alfermann A.W., Arroo R.R.J., Medarde M., Petersen M., Woolley J.G. Biosynthesis of podophyllotoxin in Linum album cell cultures. Planta. 215:2002;1031-1039
152. Shi Q., Wang H.K., Bastow K.F., Tachibana Y., Chen K., Lee F.Y., Lee K.H. Antitumor agents 210. Synthesis and evaluation of taxoid-epipodophyllotoxin conjugates as novel cytotoxic agents. Bioorg. Med. Chem. 9:2001;2999-3004
153. Strand A., Brinkeborn R.M., Siboulet A. Topical treatment of genital warts in men, an open study of podophyllotoxin cream compared with solution. Genitourin. Med. 71:1995;387-390
154. Subrahmanyam D., Renuka B., Rao C.V., Sagar P.S., Deevi D.S., Babu J.M., Vyas K. Novel D-ring analogues of podophyllotoxin as potent anti-cancer agents. Bioorg. Med. Chem. Lett. 8:1998;1391-1396
155. Subrahmanyam D., Renuka B., Kumar G.S., Vandana V., Deevi D.S. 9-deoxopodophyllotoxin derivatives as anti-cancer agents. Bioorg. Med. Chem. Lett. 9:1999;2131-2134
156. Sudo K., Konno K., Shigeta S., Yokota T. Inhibitory effects of podophyllotoxin derivatives on herpes simplex virus replication. Antivir. Chem. Chemother. 9:1998;263-267
157. Suzuki S., Sakakibara N., Umezawa T., Shimada M. Survey and enzymatic formation of lignans of Anthriscus sylvestris. J. Wood Sci. 48:2002;536-541
158. Syed T.A., Lundin S., Ahmad M. Topical 0.3% and 0.5% podophyllotoxin cream for self-treatment of Molluscum contagiosum in males. A placebo-controlled, double-blind study. Dermatology. 189:1994;65-68
159. Syed T.A., Cheema K.M., Khayyami M., Ahmad S.A., Ahmad S.H., Ahmad S. Human leukocyte interferon-α versus podophyllotoxin in cream for the treatment of genital warts in males. A placebo-controlled, double-blind, comparative study. Dermatology. 191:1995;129-132
160. Tachibana Y., Zhu X.K., Krishnan P., Lee K.H., Bastow K.F. Characterization of human lung cancer cells resistant to 4′-O-demethyl- 4β-(2″-nitro-4″-fluoroanilino)-4-desoxypodophyllotoxin, a unique compound in the epipodophyllotoxin antitumor class. Anticancer Drugs. 11:2000;19-28
161. Tao L., Wang Y.G., Ma C., Zheng B., Chen Y.Z. Synthesis of novel 4β-1,2,3-triazol-1-yl) podophyllotoxins as potential antitumor drugs. Synth. Commun. 29:1999;2053-2059
162. Tratrat C., Giorgi-Renault S., Husson H.P. A multicomponent reaction for the one-pot synthesis of 4-aza-2,3-didehydropodophyllotoxin and derivatives. Org. Lett. 4:2002;3187-3189
163. Truedsson L., Sjoholm A.G., Stiurfelt G. Complement activating rheumatoid factors in rheumatoid arthritis studied by haemolysis in gel: relation to antibody class and response to treatment with podophyllotoxin derivatives. Clin. Exp. Rheumatol. 3:1985;29-37
164. Tseng C.J., Wang Y.J., Liang Y.C., Jeng J.H., Lee W.S., Lin J.K., Chen C.H., Liu I.C., Ho Y.S. Microtubule damaging agents induce apoptosis in HL 60 cells and G2/M cell cycle arrest in HT 29 cells. Toxicology. 175:2002;123-142
165. Udino L., Abaul J., Bourgeois P., Gorrichon L., Duran H., Zedde C. Lignans from the seeds of Hernandia sonora. Planta Med. 65:1999;279-281
166. Utsugi T., Shibata J., Sugimoto Y., Aoyagi K., Wierzba K., Kobunai T., Terada T., Oh-hara T., Tsuruo T., Yamada Y. Antitumor activity of a novel podophyllotoxin derivative (TOP-53) against lung cancer and lung metastatic cancer. Cancer Res. 56:1996;2809-2814
167. Van Maanen J.M.S., Lafleur M.V.M., Mans D.R.A., van den Akker E., de Ruiter C., Kootstra P.R., Pappie D., de Vries J., Retel J., Pinedo H.M. Effects of the ortho-quinone and catechol of the antitumor drug VP-16-213 on the biological activity of single-stranded and double-stranded phi X174 DNA. Biochem. Pharmacol. 37:1988;3579-3589
168. Van Uden W., Pras N., Malingré T.M. On the improvement of the podophyllotoxin production by phenylpropanoid precursor feeding to cell cultures of Podophyllum hexandrum Royle. Plant Cell Tiss. Org. Cult. 23:1990;217-224
169. Van Uden W., Bouma A.S., Bracht Waker J.F., Middel O., Wichers H.J., De Waard P., Woerdenbag H.J., Kellogg R.M., Pras N. The production of podophyllotoxin and its 5-methoxy derivative through bioconversion of cyclodextrin-complexed deoxypodophyllotoxin by plant cell cultures. Plant Cell Tiss. Org. Cult. 42:1995;73-79
170. Van Uden W., Bos J.A., Boeke G.M., Woerdenbag H.J., Pras N. The large-scale isolation of deoxypodophyllotoxin from rhizomes of Anthriscus sylvestris followed by its bioconversion into 5-methoxypodophyllotoxin β-D-glucoside by cell cultures of Linun flavum. J. Nat. Prod.
171. Van Vliet D.S., Lee K.H. A high yield preparation of 2- fluoropodophyllotoxin. Tetrahedron Lett. 40:1999;2259-2262
172. Van Vliet D.S., Tachibana Y., Bastow K.F., Huang E.S., Lee K.H. Antitumor agents. 207. Design, synthesis, and biological testing of 4β-anilino-2- fluoro-4′-demethylpodophyllotoxin analogues as cytotoxic and antiviral agents. J. Med. Chem. 44:2001;1422-1428
173. Von Wartburg A., Stähelin H. Etoposide. Lednicer D. Chronicles of Drug Discovery. 1993;349-380 American Chemical Society, Washington, DC
174. Wang I.Z., Tian X., Tsumora H. Antitumor activity of a new low immunosuppressive derivative of podophyllotoxin (GP-11) and its mechanisms. Anticancer Drug Des. 8:1993;193-202
175. Wang J.Q., Zheng J., Cheng L., Li W.G., Su Z.X. Preparation of new polymer from podophyllotoxin derivative. Polym. Bull. 47:2001;223-230
176. Wantke F., Flieschl G., Jarisch R. Topical podophyllotoxin in psoriasis vulgaris. Dermatology. 186:1993;79
177. Ward R.S. Lignans, neolignans, and related compounds. Nat. Prod. Rep. 10:1993;1-28
178. Ward R.S. Lignans, neolignans, and related compounds. Nat. Prod. Rep. 12:1995;183-205
179. Ward R.S. Lignans, neolignans, and related compounds. Nat. Prod. Rep. 14:1997;43-74
180. Ward R.S. Lignans, neolignans and related compounds. Nat. Prod. Rep. 16:1999;75-96
181. Watson M.A., Scott K., Griffith J., Dieter S., Jones C.S., Nanda S. The developmental ecology of mycorrhizal associations in mayapple, Podophyllum peltatum, Berberidaceae. Evo. Ecol. 15:2001;425-442
182. Whiting D.A. Lignans and neolignans. Nat. Prod. Rep. 2:1985;191-211
183. Whiting D.A. Lignans, neolignans, and related compounds. Nat. Prod. Rep. 4:1987;499-525
184. Whiting D.A. Lignans, neolignans, and related compounds. Nat. Prod. Rep. 7:1990;349-364
185. Wilson J. Treatment of genital warts - what's the evidence? Int. J. STD AIDS. 13:2002;216-222
186. Wrasidlo W., Schröder U., Bernt K., Hübener N., Shabat D., Gaedicke G., Lode H. Synthesis, hydrolytic activation and cytotoxicity of etoposide prodrugs. Bioorg. Med. Chem. Lett. 12:2002;557-560
187. Xia Z.Q., Costa M.A., Proctor J., Davin L.B., Lewis N.G. Dirigent-mediated podophyllotoxin biosynthesis in Linum flavum and Podophyllum peltatum. Phytochemistry. 55:2000;537-549
188. Xia Z.Q., Costa M.A., Pelissier H.C., Davin L.B., Lewis N.G. Secoisolariciresinol dehydrogenase purification, cloning, and functional expression - implications for human health protection. J. Biol. Chem. 276:2001;12614-12623
189. Xu H., Zhang X., Tian X., Lu M., Wang Y.G. Synthesis and insecticidal activity of novel 4α-halogenated benzoylamino podophyllotoxins against Pieris rapae Linnaeus. Chem. Pharm. Bull. 50:2002;399-402
190. You J.Z., Chen Y.Z. Two new methods for synthesis of 4β-amino-4- deoxypodophyllotoxin and 4β-amino-4′-demethyl-4-deoxypodophyllotoxin. Chem. J. Chin. 21:2000;1064-1066
191. Yu Y.P.C., Chen S.Y., Wang Y.G., Chen Y.Z. A facile and efficient synthesis of 4 β-aminopodophyllotoxins. Tetrahedron Lett. 40:1999;1967-1970
192. Zacchino S., Rodríguez G., Pezzenati G., Orellana G. In vitro evaluation of antifungal properties of 8.O.4′-neolignans. J. Nat. Prod. 60:1997;659-662
193. Zhang F.M., Tian X. Synthesis and anti-cancer activity of novel derivatives of 4′-demethylepipodophyllotoxin. Acta Chim. Sin. 60:2002;720-724
194. Zhao C.Q., Huang J., Nagatsu A., Ogihara Y. Two new podophyllotoxin glucosides from Sinopodophyllum emodi (Wall.). Ying. Chem. Pharm. Bull. 49:2001;773-775
195. Zhao C.Q., Cao W., Nagatsu A., Ogihara Y. Three new glycosides from Sinopodophyllum emodi (Wall.). Ying. Chem. Pharm. Bull. 49:2001;1474-1476
196. Zhao C., Nagatsu A., Hatano K., Shirai N., Kato S., Ogihara Y. New lignan glycosides from chinese medicinal plant, Sinopodophillum emodi. Chem. Pharm. Bull. 51:2003;255-261
197. Zhu X.K., Guan J., Tachibana Y., Bastow K.F., Cho S.J., Cheng H.H., Cheng Y.C., Gurwith M., Lee K.H. Antitumor agents. 194. Synthesis and biological evaluations of 4β-mono-, di-, and -trisubstituted aniline-4′-O- demethyl-podophyllotoxin and related compounds with improved pharmacological profiles. J. Med. Chem. 42:1999;2441-2446